Responses
Clinical/translational cancer immunotherapy
Original research
Nivolumab and ipilimumab in combination with radiotherapy in patients with high-risk locally advanced squamous cell carcinoma of the head and neck
Compose a Response to This Article
Other responses
No responses have been published for this article.
